Immunotherapy: Open Access
Open Access

The Approaches and Safer Treatments of Immunotherapy to Treat Auto Immune Diseases

Samuel Klempner^{* *}Correspondence: Samuel Klempner, Department of Microbiology, University of Bejaia, Targa Ouzemour, Bejaia, Algeria, Email:

Author info »

Description

Autoimmune diseases, where the body's immune system mistakenly attacks its own tissues, affect millions worldwide, leading to chronic illness and disability. Common autoimmune diseases include rheumatoid arthritis, multiple sclerosis, type 1 diabetes and lupus. Traditional treatments often involve immunosuppressive drugs that reduce the immune system's activity broadly, but these can lead to severe side effects and increase the risk of infections. Immunotherapy, a rapidly advancing field, offers more targeted approaches to modulate the immune system and holds assurance for more effective and safer treatments for autoimmune diseases.

Understanding immunotherapy

Immunotherapy leverages the body's immune system to fight diseases, a concept that has revolutionized cancer treatment and is now making significant inroads into autoimmune disease management. Unlike traditional therapies, immunotherapy aims to correct the underlying immune dysfunction rather than merely alleviate symptoms.

Types of immunotherapy for autoimmune diseases

Biologic agents: Biologic therapies use molecules that can specifically target components of the immune system. Tumor Necrosis Factor (TNF) inhibitors, such as infliximab and adalimumab, are already used to treat conditions like rheumatoid arthritis and Crohn's disease. These drugs block TNF, a substance in the body that causes inflammation in autoimmune diseases. Other biologics target different molecules, such as interleukins and B cells, offering precision in treating specific autoimmune conditions.

Checkpoint inhibitors: Initially developed for cancer treatment, checkpoint inhibitors can also modulate the immune response in autoimmune diseases. These drugs interfere with the proteins that prevent immune cells from attacking the body's tissues, thus enhancing immune activity against self-antigens in a controlled manner. Many studies is ongoing to adapt this approach for autoimmune conditions, aiming to achieve a balance where the immune system can be directed against pathogenic cells without causing widespread damage.

Adoptive Cell Transfer (ACT): ACT involves extracting immune cells from a patient, modifying or expanding them in the lab to enhance their activity against disease and then reinfusing them into the patient. In autoimmune diseases, this could mean boosting regulatory T cells that suppress immune responses or modifying effector T cells to reduce their activity against selftissues. Clinical trials are exploring the safety and efficacy of ACT in conditions like multiple sclerosis and type 1 diabetes.

Vaccination strategies: Unlike traditional vaccines that protect against infections, therapeutic vaccines for autoimmune diseases aim to induce tolerance to specific autoantigens. These vaccines train the immune system to recognize self-antigens as harmless, thereby reducing the autoimmune attack. Early-stage trials for diseases like multiple sclerosis and type 1 diabetes show assurance in using this approach to induce long-lasting remission.

Challenges and future directions

While immunotherapy offers great assurance, it also presents significant challenges. The immune system is highly complex and interventions that work well in one context may have unintended consequences in another. For instance, enhancing immune activity to fight cancer or infections might exacerbate autoimmune conditions. Conversely, suppressing immune responses to treat autoimmunity might increase the risk of infections or cancer.

Personalized medicine is key to overcoming these challenges. By understanding the genetic, environmental and immunological factors that contribute to each patient's disease, therapies can be made to individual needs. Advances in genomics, proteomics and bioinformatics are facilitating this approach, allowing for more precise and effective interventions.

Immunotherapy represents a paradigm shift in the treatment of autoimmune diseases. By targeting specific components of the immune system, these therapies offer the potential for greater efficacy and fewer side effects compared to traditional treatments. Ongoing studies and clinical trials are expanding our understanding of how to harms the immune system's power to fight autoimmune diseases safely and effectively.